Immunotherapy Forum Video #22: Drs. Lauren Harshman and Sumanta (Monty) Pal answer questions from the audience following their presentations on immunotherapy for kidney cancer. Moderated by Dr. Marianne Davies.
Podcast: Play in new windowDownload
Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.
Among kidney cancer patients, the sub-type “non-clear cell” is the least common. As a result, not much research has been conducted on it.
Subscribe toGRACE Notes (Free Newsletter)
Mission | Disclaimer